Invesco Biotechnology & Genome ETF
PBE
PBE
71 hedge funds and large institutions have $61.8M invested in Invesco Biotechnology & Genome ETF in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 21
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $11K
Holders
71
Holding in Top 10
1
Calls
–
Puts
$11K
Top Buyers
| 1 | +$1.05M | |
| 2 | +$1.03M | |
| 3 | +$868K | |
| 4 |
SB
Suntrust Banks
Atlanta,
Georgia
|
+$600K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$470K |
Top Sellers
| 1 | -$9.64M | |
| 2 | -$6.25M | |
| 3 | -$4.04M | |
| 4 |
GKWIM
Gerber Kawasaki Wealth & Investment Management
Santa Monica,
California
|
-$2.67M |
| 5 |
BWP
Baldwin Wealth Partners
Marion,
Massachusetts
|
-$1.81M |